CIK: 1704483 - Address: C/o Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT 06510
21 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret111-100000-1
P%wins00

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
7/10/20 21:15
7/8/20
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOSpecial M.d360.61000588791D
7/10/20 21:15
7/8/20
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOSpecial S.d-4,39575.250-58-7791D
6/25/20 21:49
6/23/20
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOSpecial M.d30.6100041791D
6/25/20 21:49
6/23/20
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOSpecial S.d-32275.050-4-1791D
6/22/20 21:57
6/18/20
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOSpecial M.dm1632.610629791D
6/22/20 21:57
6/18/20
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOSpecial S.dm-4,68975.270-62-7791D
12/31/19 19:33
12/30/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOSpecial M.d760.6100012519791D
12/31/19 19:33
12/30/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOSpecial S.d-6,65253.220-125-14791D
12/20/19 21:42
12/18/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOSpecial M.d00.00010791D
6/28/19 07:09
6/27/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOChief MeP10642.30030791I
6/20/18 21:29
6/11/18
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOChief MeS.am-2,78936.360-77-24244I
6/12/18 16:12
6/8/18
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOChief MeS.m-3,78436.330-104-12785I
6/7/18 16:29
6/5/18
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOChief MeS.m-93136.010-26-3898I
5/14/18 17:11
5/10/18
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOChief MeS-93926.820-35-4924I
4/12/18 17:02
4/10/18
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOChief MeS-86324.660-35-4959I
3/14/18 17:05
3/12/18
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOChief MeS-1,05430.110-35-3994I
1/12/18 18:59
1/10/18
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOChief MeS-96327.520-35-31,070I
12/20/17 17:57
12/19/17
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOChief MeS-24124.100-10-11,105I
12/14/17 07:08
12/11/17
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOChief MeS-53221.280-25-21,115I
11/14/17 17:51
11/9/17
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOChief MeS.m-4,12225.760-160-121,140I
5/11/17 16:58
5/9/17
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBerman RobertCTOChief MeP117.0020001,300I22-1

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact